Epidemiology of visceral mycoses:: Analysis of data in Annual of the Pathological Autopsy Cases in Japan

被引:82
作者
Yamazaki, T
Kume, H
Murase, S
Yamashita, E
Arisawa, M
机构
[1] Nippon Roche Res Ctr, Dept Mycol, Kanagawa 2478530, Japan
[2] Kitasato Univ, Univ Hosp, Sch Med, Dept Pathol, Kanagawa 2288550, Japan
[3] Kitasato Univ, Univ Hosp, Sch Med, Dept Drug Informat, Kanagawa 2288550, Japan
[4] Kitasato Univ, Univ Hosp, Sch Med, Dept Internal Med, Kanagawa 2288550, Japan
关键词
D O I
10.1128/JCM.37.6.1732-1738.1999
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The data on visceral mycoses that had been reported in the Annual of the Pathological Autopsy Cases in Japan from 1969 to 1994 by the Japanese Society of Pathology mere analyzed epidemiologically, The frequency of visceral mycoses among the annual total number of pathological autopsy cases increased noticeably from 1.60% in 1969 to a peak of 4.66% in 1990. Among them, the incidences of candidiasis and aspergillosis increased the most. After 1990, however, the frequency of visceral mycoses decreased gradually. Until 1989, the predominant causative agent was Candida, followed in order by Aspergillus and Cryptococcus, Although the rate of candidiasis decreased by degrees from 1990, the rate of aspergillosis increased up to and then surpassed that of candidiasis in 1991, Leukemia was the major disease underlying the visceral mycoses, followed by solid cancers and other blood and hematopoietic system diseases. Severe mycotic infection has increased over the reported 25-year period, from 6.6% of the total visceral mycosis cases in 1969 to 71% in 1994, The reasons for this decrease of candidiasis combined with an increase of aspergillosis or of severe mycolic infection might be that (i) nonsevere (not disseminated) infections were excluded from the case totals, since they have become controllable by antifungal drugs such as fluconazole, but (iii) the available antifungal drugs were not efficacious against severe infections such as pulmonary aspergillosis, and (iii) the number of patients living longer in an immunocompromised state had increased because of developments in chemotherapy and progress in medical care.
引用
收藏
页码:1732 / 1738
页数:7
相关论文
共 55 条
[1]   SAFETY, PLASMA-CONCENTRATIONS, AND EFFICACY OF HIGH-DOSE FLUCONAZOLE IN INVASIVE MOLD INFECTIONS [J].
ANAISSIE, EJ ;
KONTOYIANNIS, DP ;
HULS, C ;
VARTIVARIAN, SE ;
KARL, C ;
PRINCE, RA ;
BOSSO, J ;
BODEY, GP .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (02) :599-602
[2]  
BANERJEE SN, 1991, AM J MED S3B, V91, P86
[3]  
BOYDEY G, 1992, EUR J CLIN MICROBIOL, V11, P99
[4]  
Castagnola E, 1996, BONE MARROW TRANSPL, V18, P97
[5]  
Chakrabarti A, 1996, INDIAN J MED RES, V104, P171
[6]  
COMO JA, 1994, NEW ENGL J MED, V330, P263, DOI 10.1056/NEJM199401273300407
[7]   Itraconazole resistance in Aspergillus fumigatus [J].
Denning, DW ;
Venkateswarlu, K ;
Oakley, KL ;
Anderson, MJ ;
Manning, NJ ;
Stevens, DA ;
Warnock, DW ;
Kelly, SL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (06) :1364-1368
[8]   Invasive aspergillosis [J].
Denning, DW .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :781-803
[9]   Mixed oropharyngeal candidiasis due to Candida albicans and non-albicans Candida strains in HIV-infected patients [J].
Dronda, F ;
AlonsoSanz, M ;
Laguna, F ;
Chaves, F ;
MartinezSuarez, JV ;
RodriguezTudela, JL ;
GonzalezLopez, A ;
Valencia, E .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (06) :446-452
[10]   Zygomycosis [J].
Elgart, ML .
DERMATOLOGIC CLINICS, 1996, 14 (01) :141-+